C. Kenney

Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies

C. Hoang, Julie A Hong, Mary R. Zhang, 2021, Translational lung cancer research.

Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma

Edward J. Kim, S. Steinberg, Tricia F. Kunst, 2021, Investigational New Drugs.

Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy

Jonathan M. Hernandez, S. Steinberg, A. Letai, 2018, BMC Gastroenterology.